Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...

The consensus price target for CRISPR Therapeutics AG (NASDAQ:CRSP) has been adjusted from $72.75 to $65, reflecting changes in financial performance and industry developments. Despite a quarterly ...

The 2024/25 UEFA Champions League boasts a complete reorganization of the way clubs qualify for the knockout stage. With the old group stage scrapped, teams now battle all 35 other clubs in the ...